Covaxin will now also be tested on infants as young as two years, Bharat Biotech chairman and managing director Dr Krishna Ella said on Monday. “…We are now planning a clinical trial on children between two and 15 years. We are going to submit (proposal) to SEC (subject expert committee) soon for that,” Ella said during a virtual interaction with reporters. Pointing out that Covaxin is an inactivated virus vaccine based on a tried and tested vero cell platform that has been used for multiple vaccines, he said: “The injectable polio vaccine we have given to a newborn baby… it’s a proven platform and the safest to give to children.”from India News | Latest News Headlines & Live Updates from India - Times of India https://ift.tt/3rMXsay
कोई टिप्पणी नहीं:
एक टिप्पणी भेजें